Physician profile
Mariola Traba
NPI 1164060117
$2,479.80
in general payments reported to CMS, 2019-2025
19 companies · $728 in 2025
The $728 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $272 · 2023: $315 · 2024: $920 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,845 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,845.24 |
| Education | $117.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $527.85 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $287.54 | 2023-2025 | Rexulti |
| Pfizer INC. | $252.64 | 2022-2025 | |
| Abbvie INC. | $242.38 | 2021-2025 | |
| Amgen INC. | $198.05 | 2023-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $151.04 | 2023-2025 | Veozah |
| Lilly USA, LLC | $149.51 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Lundbeck LLC | $117.29 | 2024-2025 | Rexulti |
| Exact Sciences Corporation | $103.93 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $68.39 | 2022-2024 | Arexvy, Shingrix |
| Cranial Technologies, INC | $58.76 | 2021-2024 | Doc Band |
| Hologic Sales and Service, LLC | $58.19 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $57.03 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $56.97 | 2022 | |
| Merck Sharp & Dohme LLC | $47.53 | 2022-2023 | Vaxneuvance, Gardasil 9 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $41.64 | 2024 | Inspire |
| Phadia US INC. | $32.34 | 2023-2025 | Immunocap |
| Redhill Biopharma INC. | $16.40 | 2021 | |
| Avion Pharmaceuticals | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariola Traba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.